The most accurate at-home COVID-19 test is a molecular test, not the common rapid antigen test most people are familiar with. Molecular home tests detect about 93% of true infections, compared to roughly 75% for rapid antigen tests. Both types are widely available, but they differ significantly in how they work, what they cost, and how reliably they catch an active infection.
Molecular vs. Antigen: The Accuracy Gap
At-home COVID tests fall into two categories: rapid antigen tests and rapid molecular tests. Antigen tests look for proteins on the surface of the virus. Molecular tests amplify and detect the virus’s genetic material, which makes them far more sensitive to small amounts of virus in your sample.
A large review published in BMC Medicine found that molecular rapid tests had a sensitivity of 93%, meaning they correctly identified 93 out of 100 infected people. Rapid antigen tests had a sensitivity of 75%, missing about one in four infections. Both types performed nearly identically on specificity (around 98 to 99%), so false positives are rare with either one. The meaningful difference is in false negatives: antigen tests are much more likely to tell you you’re negative when you’re actually infected.
The Lucira COVID-19 All-In-One Test Kit, which was the most prominent molecular home test, achieved 94% agreement with high-sensitivity lab tests in its clinical trials. When samples with extremely low viral loads were excluded, that number hit 100%. Molecular home tests deliver results in about 30 minutes, compared to 10 to 15 minutes for antigen tests, and they typically cost more (often $30 to $75 versus $5 to $15 per antigen test).
How Antigen Tests Compare by Brand
If you’re using a rapid antigen test, brand choice matters less than you might think. A study evaluating five popular at-home antigen tests against Omicron samples found their sensitivity clustered in a relatively narrow range. QuickVue performed best at 84.3%, followed by On/Go at 76.4%, iHealth at 73.0%, BinaxNOW at 69.7%, and InBios at 66.3%. Importantly, none of these tests showed a significant drop in sensitivity between Omicron and earlier variants, meaning antigen tests have continued to work reasonably well as the virus has evolved.
The practical takeaway: no single antigen brand dramatically outperforms the others. The bigger factor in your result’s reliability is when and how you test, not which box you grab off the shelf.
Why Timing Changes Everything
An at-home test taken at the wrong time can be nearly useless. On the very first day of infection, a single antigen test catches only about 60% of symptomatic infections and fewer than 10% of asymptomatic ones. Viral load needs time to build before it’s detectable, especially with the less sensitive antigen format.
If you’ve been exposed but have no symptoms, Harvard University Health Services recommends waiting at least five full days after exposure before testing. Testing too early is one of the most common reasons people get a false negative and unknowingly spread the virus.
For symptomatic people, the test performs best a few days after symptoms begin, when viral levels in the nose are peaking. If you test the moment you feel a scratchy throat and get a negative result, that doesn’t necessarily mean you’re in the clear.
Serial Testing Closes the Gap
The single most effective way to improve the accuracy of a rapid antigen test is to use more than one. Testing twice, 48 hours apart, boosted sensitivity to 93.4% in symptomatic people during the first week of infection. That’s comparable to a single molecular test. For asymptomatic people, two tests 48 hours apart raised detection from about 34% to 55%, and three tests over five days pushed it to roughly 69 to 79%.
This is why the FDA authorizes most antigen tests for serial use: two tests over three days if you have symptoms, or three tests over five days if you don’t. A single antigen test is a snapshot. Serial testing turns it into something much closer to a reliable answer.
Asymptomatic Testing Is the Weak Spot
At-home tests perform worst in people without symptoms. A CDC study at two university campuses found that antigen test sensitivity dropped to just 41% in asymptomatic individuals, compared to 80% in people with symptoms. That means nearly 6 out of 10 asymptomatic infections were missed by a single test.
This isn’t a flaw unique to one brand. It reflects the biology of infection: people without symptoms often carry lower viral loads in their nasal passages, and antigen tests need a certain threshold of virus to trigger a positive result. If you’re testing before a visit with someone vulnerable and feel fine, serial testing or a molecular test gives you much better odds of catching an infection you can’t feel.
How You Swab Matters More Than You Think
Most at-home tests instruct you to swab just inside your nostrils. But a growing body of research suggests that adding a throat swab can meaningfully improve detection, especially early in infection when the virus may be replicating in the throat before it reaches high levels in the nose.
Studies have found that combining a throat and nasal swab improved antigen test sensitivity by 13 to 24%, depending on the test brand. A large Danish study of over 800 infected people found a 16% improvement. During the first few days of infection, when nasal viral loads are still building, a combined throat-nasal approach could improve sensitivity by more than 40% for molecular tests.
Not all test manufacturers have validated throat swabbing in their instructions, so this remains an off-label technique. But the evidence is consistent: if you swab your throat first (back of the throat and tonsils) and then your nostrils with the same swab, you’re giving the test more virus to work with.
Picking the Right Test for Your Situation
Your best choice depends on what you’re trying to accomplish. If you have symptoms and want the most accurate single result, a molecular home test is the clear winner at 93 to 94% sensitivity. If cost or availability is a concern, a rapid antigen test used twice over 48 hours reaches similar accuracy for symptomatic people.
If you’re asymptomatic and testing as a precaution before seeing someone at high risk, a molecular test is strongly preferable. No amount of serial antigen testing fully compensates for the inherent difficulty of catching low-viral-load infections with an antigen format, though three tests over five days gets you into a reasonable range.
Regardless of which test you use, timing and technique are at least as important as the test itself. Wait an appropriate interval after exposure, repeat the test if your first result is negative but you still suspect infection, and consider swabbing your throat along with your nose to give the test the best possible sample.